Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells

Mutations in p53, especially gain of function (GOF) mutations, are highly frequent in lung cancers and are known to facilitate tumor aggressiveness. Yet, the links between mutant GOF-p53 and lung cancers are not well established. In the present study, we set to examine how we can better sensitize re...

Full description

Bibliographic Details
Main Authors: Heena Saini, Ifrah Hakeem, Sudeshna Mukherjee, Shibasish Chowdhury, Rajdeep Chowdhury
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Oncology
Online Access:http://dx.doi.org/10.1155/2019/6164807
id doaj-6689f6ef50f64a4da808589670ad4b78
record_format Article
spelling doaj-6689f6ef50f64a4da808589670ad4b782020-11-24T22:05:34ZengHindawi LimitedJournal of Oncology1687-84501687-84692019-01-01201910.1155/2019/61648076164807Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer CellsHeena Saini0Ifrah Hakeem1Sudeshna Mukherjee2Shibasish Chowdhury3Rajdeep Chowdhury4Department of Biological Sciences, Pilani Campus, BITS, Pilani, Rajasthan 333031, IndiaDepartment of Biological Sciences, Pilani Campus, BITS, Pilani, Rajasthan 333031, IndiaDepartment of Biological Sciences, Pilani Campus, BITS, Pilani, Rajasthan 333031, IndiaDepartment of Biological Sciences, Pilani Campus, BITS, Pilani, Rajasthan 333031, IndiaDepartment of Biological Sciences, Pilani Campus, BITS, Pilani, Rajasthan 333031, IndiaMutations in p53, especially gain of function (GOF) mutations, are highly frequent in lung cancers and are known to facilitate tumor aggressiveness. Yet, the links between mutant GOF-p53 and lung cancers are not well established. In the present study, we set to examine how we can better sensitize resistant GOF-p53 lung cancer cells through modulation of cellular protein degradation machineries, proteasome and autophagy. H1299 p53 null lung cancer cells were stably transfected with R273H mutant GOF-p53 or wild-type (wt) p53 or empty vectors. The presence of R273H-P53 conferred the cancer cells with drug resistance not only against the widely used chemotherapeutic agents like cisplatin (CDDP) or 5-flurouracil (5-FU) but also against potent alternative modes of therapy like proteasomal inhibition. Therefore, there is an urgent need for new strategies that can overcome GOF-p53 induced drug resistance and prolong patient survival following failure of standard therapies. We observed that the proteasomal inhibitor, peptide aldehyde N-acetyl-leu-leu-norleucinal (commonly termed as ALLN), caused an activation of cellular homeostatic machinery, autophagy in R273H-P53 cells. Interestingly, inhibition of autophagy by chloroquine (CQ) alone or in combination with ALLN failed to induce enhanced cell death in the R273H-P53 cells; however, in contrast, an activation of autophagy by serum starvation or rapamycin increased sensitivity of cells to ALLN-induced cytotoxicity. An activated autophagy was associated with increased ROS and ERK signaling and an inhibition of either ROS or ERK signaling resulted in reduced cytotoxicity. Furthermore, inhibition of GOF-p53 was found to enhance autophagy resulting in increased cell death. Our findings provide novel insights pertaining to mechanisms by which a GOF-p53 harboring lung cancer cell is better sensitized, which can lead to the development of advanced therapy against resistant lung cancer cells.http://dx.doi.org/10.1155/2019/6164807
collection DOAJ
language English
format Article
sources DOAJ
author Heena Saini
Ifrah Hakeem
Sudeshna Mukherjee
Shibasish Chowdhury
Rajdeep Chowdhury
spellingShingle Heena Saini
Ifrah Hakeem
Sudeshna Mukherjee
Shibasish Chowdhury
Rajdeep Chowdhury
Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells
Journal of Oncology
author_facet Heena Saini
Ifrah Hakeem
Sudeshna Mukherjee
Shibasish Chowdhury
Rajdeep Chowdhury
author_sort Heena Saini
title Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells
title_short Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells
title_full Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells
title_fullStr Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells
title_full_unstemmed Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells
title_sort autophagy regulated by gain of function mutant p53 enhances proteasomal inhibitor-mediated cell death through induction of ros and erk in lung cancer cells
publisher Hindawi Limited
series Journal of Oncology
issn 1687-8450
1687-8469
publishDate 2019-01-01
description Mutations in p53, especially gain of function (GOF) mutations, are highly frequent in lung cancers and are known to facilitate tumor aggressiveness. Yet, the links between mutant GOF-p53 and lung cancers are not well established. In the present study, we set to examine how we can better sensitize resistant GOF-p53 lung cancer cells through modulation of cellular protein degradation machineries, proteasome and autophagy. H1299 p53 null lung cancer cells were stably transfected with R273H mutant GOF-p53 or wild-type (wt) p53 or empty vectors. The presence of R273H-P53 conferred the cancer cells with drug resistance not only against the widely used chemotherapeutic agents like cisplatin (CDDP) or 5-flurouracil (5-FU) but also against potent alternative modes of therapy like proteasomal inhibition. Therefore, there is an urgent need for new strategies that can overcome GOF-p53 induced drug resistance and prolong patient survival following failure of standard therapies. We observed that the proteasomal inhibitor, peptide aldehyde N-acetyl-leu-leu-norleucinal (commonly termed as ALLN), caused an activation of cellular homeostatic machinery, autophagy in R273H-P53 cells. Interestingly, inhibition of autophagy by chloroquine (CQ) alone or in combination with ALLN failed to induce enhanced cell death in the R273H-P53 cells; however, in contrast, an activation of autophagy by serum starvation or rapamycin increased sensitivity of cells to ALLN-induced cytotoxicity. An activated autophagy was associated with increased ROS and ERK signaling and an inhibition of either ROS or ERK signaling resulted in reduced cytotoxicity. Furthermore, inhibition of GOF-p53 was found to enhance autophagy resulting in increased cell death. Our findings provide novel insights pertaining to mechanisms by which a GOF-p53 harboring lung cancer cell is better sensitized, which can lead to the development of advanced therapy against resistant lung cancer cells.
url http://dx.doi.org/10.1155/2019/6164807
work_keys_str_mv AT heenasaini autophagyregulatedbygainoffunctionmutantp53enhancesproteasomalinhibitormediatedcelldeaththroughinductionofrosanderkinlungcancercells
AT ifrahhakeem autophagyregulatedbygainoffunctionmutantp53enhancesproteasomalinhibitormediatedcelldeaththroughinductionofrosanderkinlungcancercells
AT sudeshnamukherjee autophagyregulatedbygainoffunctionmutantp53enhancesproteasomalinhibitormediatedcelldeaththroughinductionofrosanderkinlungcancercells
AT shibasishchowdhury autophagyregulatedbygainoffunctionmutantp53enhancesproteasomalinhibitormediatedcelldeaththroughinductionofrosanderkinlungcancercells
AT rajdeepchowdhury autophagyregulatedbygainoffunctionmutantp53enhancesproteasomalinhibitormediatedcelldeaththroughinductionofrosanderkinlungcancercells
_version_ 1725825687059693568